Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation.
Maki KomiyamaHiromichi WadaHajime YamakageNoriko Satoh-AsaharaYoichi SunagawaTatsuya MorimotoYuka OzakiAkira ShimatsuYuko TakahashiKoji HasegawaPublished in: PloS one (2018)
Despite weight gain and increased abdominal obesity, serum adiponectin levels did not decrease after SC. Therefore, the beneficial effect of SC may eliminate the adverse effects of subsequent weight gain. Conversely, patients with less abdominal obesity had increased adiponectin levels 1 year after SC. Therefore, in such patients, the beneficial effect of SC on adiponectin levels is apparent.
Keyphrases
- weight gain
- metabolic syndrome
- insulin resistance
- body mass index
- birth weight
- smoking cessation
- weight loss
- end stage renal disease
- type diabetes
- high fat diet induced
- adipose tissue
- ejection fraction
- chronic kidney disease
- newly diagnosed
- emergency department
- replacement therapy
- skeletal muscle
- magnetic resonance imaging
- peritoneal dialysis
- patient reported outcomes
- computed tomography
- gestational age